Oral Anticoagulants in Atrial Fibrillation with Severe or End Stage Chronic Kidney Disease. The Lack of Strong Evidence and the Current Trends Toward a Better Practice. A Mini Review | Zendy

AI Assistant Blog Pricing

Oral Anticoagulants in Atrial Fibrillation with Severe or End Stage Chronic Kidney Disease. The Lack of Strong Evidence and the Current Trends Toward a Better Practice. A Mini Review

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.